Skip to main content
Caplight Logo









Kimer Med

Kimer Med

Private
NelsonHealthcare & Life Scienceshttps://www.kimermed.co.nz/

Last Round

Series A

Oct 1, 2024

Total Funding Raised

$11.45M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kimer Med is a biotechnology company that develops broad-spectrum antiviral therapeutics to treat viral diseases and support pandemic preparedness.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

broad-spectrum antiviralbiotechnologydrug discoverypandemic preparednessrecombinant proteinmedical countermeasuresbiologicspreclinical developmentantiviral researchtherapeutic interventiondrug developmentpharma R&Dbiotech startuppandemic tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kimer Med Comparables

Compare Kimer Med with similar companies based on industry and business-model similarity.

Kimer Med comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoViricides, Inc.
76%
Avocet Bio GmbH
74%
Altesa BioSciences
73%

Kimer Med Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 1, 2024
SeedMar 31, 2021

Key People

Founding team and executive leadership

Rick Kiessig

Director and CEO

Executive Team

Kimer Med Investors

Notable investors and investment history

Kimer Med investors
InvestorRounds
Seed The Change | He Kākano HāpaiSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 90% MoM.

  • May 18, 2026

    Monthly visitors increased 123% MoM.

Kimer Med Filings

Explore SEC and related filing metadata, where available.

Kimer Med filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kimer Med's valuation, stock price, and market status.

Is Kimer Med a public or private company?

Kimer Med is a private company.

What is the current stock price of Kimer Med?

Kimer Med is a private company with no public stock price. Caplight tracks Kimer Med's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Kimer Med worth (valuation)?

Valuation information for Kimer Med is not publicly available.

Can I buy Kimer Med stock?

Kimer Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kimer Med's last funding round?

Kimer Med's most recent funding round was Series A on October 1, 2024.

Who are the main investors in Kimer Med?

Key investors in Kimer Med include Seed The Change | He Kākano Hāpai.

Will Kimer Med IPO soon?

No public IPO plans have been announced for Kimer Med.

How can I track Kimer Med secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kimer Med's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNelson
Employee Range7
Year Founded2020
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?